RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

DEVELOPING NEW POSSIBILITIES THROUGH PROGRESSIVE RESEARCH

At THAROS™, we are advancing horse health and performance through science-driven innovation. We promote equine health and wellbeing through world-class innovation. Our ground-breaking microbiome research is leading to the development of a number of future products to assist animal health through restored gut function.


Closed

  • Target

    £800,000

  • Type

    Equity

  • Close Date

    Nov 30 2018

  • Status

    Live

Tharos

NATURE POWERED BY SCIENCE Advancing Horse Health and Performance through Science-driven Innovation

  • Sector: Healthcare
  • Region: UK: South-West
  • Stage: Early stage - early revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Board In Place
  • Pre Money Valuation: £2,799,986
  • Share Price: £1.25

For information please view deal